Loading...
Found 71 Menstruation trials
A listing of Menstruation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
The study evaluates the efficacy and safety of Brenipatide vs. placebo as an add-on to ongoing MDD treatment. Eligible participants have MDD in remission or near remission with residual symptoms. They will complete a ~4-week Screening period before randomization, followed by a Double-Blind Adjunctive Treatment period until relapse, other discontinuation …
The goals of this study are to compare markers of inflammation between women and men with sickle cell disease (SCD) and to see how these markers are associated with pain from SCD. The duration of this study is 1 month, during which you would complete a blood draw every 5 …
This is a study evaluating SAR446268 as a treatment for DM1. SAR446268 is designed to deliver miRNA to pathological DMPK gene expression that leads to DM1. Patients will receive a 1-time dose of the study drug and then undergo a 5 year follow-up period to monitor safety and efficacy.
The Aim of this study is to validate community-based use of the haptic robot gym. We will test the safety of the haptic robot gym in a community-based rehabilitation setting. Milestones are 1) to quantify the safety of the system in terms of adverse events frequency and characteristics, 2) to …
The objective is to evaluate a candidate magnetoencephalography (MEG) biomarker, M50, for autism spectrum disorder (ASD) to evaluate group difference between cohorts of adults with ASD vs. typical development as well as stability over a 12-week period. A secondary objective is to determine if the EEG analog of the M50, …
This is a study evaluating Vtx-002 as a potential treatment for ALS. TDP-43 is a protein that is often dysregulated in ALS patients. Vtx-002 is designed to reduce pathological groups of TDP-43, reducing and preventing ALS pathology. Patients will receive a 1 time dose of Vtx-002 and then undergo a …
This is a 2-part, open-label study in approximately 9 adults with oHCM. Part A of the study consists of 3 cohorts of approximately 3 participants each administered a single dose of EDG-7500. Part B of the study is an optional multiple-dose treatment period in which approximately 9 participants will receive …
This is a study to evaluate AB-1009 (IP under study) in adult patients with late-onset pompe disease (LOPD). LOPD is caused by a genetic mutation resulting in a decrease in the GAA enzyme, resulting in the destruction of muscle tissue. AB-1009, administered as a one-time IV dose, is an gene …
The research study is being conducted to help physicians understand if apremilast, an oral medication, is effective in treating recurrent oral erythema multiforme (EM). Study consists of four research study visits (weeks 0,6. 12, 24, 36) and completion of a daily treatment diary during the 24 week tratment period. Week …
This study investigates the use of an investigational medication for preventing CMV in patients who have received heart or lung transplants.The study evaluates the safety and effectiveness of the investigational medication in comparison to standard treatment. It looks at how well patients tolerate the medication and its impact on their …
Please choose between Voice or SMS based delivery of verification code
or